Rohan P Joshi
Overview
Explore the profile of Rohan P Joshi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
736
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ingale K, Hong S, Hu Q, Zhang R, Osinski B, Khoshdeli M, et al.
Mod Pathol
. 2024 Dec;
38(4):100691.
PMID: 39706295
Molecular testing of tumor samples for targetable biomarkers is restricted by a lack of standardization, turnaround time, cost, and tissue availability across cancer types. Additionally, targetable alterations of low prevalence...
2.
Hu Q, Rizvi A, Schau G, Ingale K, Muller Y, Baits R, et al.
NPJ Precis Oncol
. 2024 Apr;
8(1):88.
PMID: 38594360
Microsatellite instability-high (MSI-H) is a tumor-agnostic biomarker for immune checkpoint inhibitor therapy. However, MSI status is not routinely tested in prostate cancer, in part due to low prevalence and assay...
3.
Ingale K, Hong S, Bell J, Rizvi A, Welch A, Sha L, et al.
Am J Pathol
. 2024 Mar;
194(6):1020-1032.
PMID: 38493926
Mesenchymal epithelial transition (MET) protein overexpression is a targetable event in non-small cell lung cancer and is the subject of active drug development. Challenges in identifying patients for these therapies...
4.
Osinski B, BenTaieb A, Ho I, Jones R, Joshi R, Westley A, et al.
Mod Pathol
. 2022 Oct;
35(12):1791-1803.
PMID: 36198869
To achieve minimum DNA input requirements for next-generation sequencing (NGS), pathologists visually estimate macrodissection and slide count decisions. Unfortunately, misestimation may cause tissue waste and increased laboratory costs. We developed...
5.
Joshi R, Pejaver V, Hammarlund N, Sung H, Lee S, Furmanchuk A, et al.
J Clin Virol
. 2020 Jun;
129:104502.
PMID: 32544861
Background: Testing for COVID-19 remains limited in the United States and across the world. Poor allocation of limited testing resources leads to misutilization of health system resources, which complementary rapid...
6.
Joshi R, Steiner D, Konnick E, Suarez C
Adv Exp Med Biol
. 2019 Nov;
1168:103-115.
PMID: 31713167
The past two decades have seen unprecedented advances in the field of oncogenomics. The ongoing characterization of neoplastic tissues through genomic techniques has transformed many aspects of cancer research, diagnosis,...
7.
Fernandez-Pol S, Ma L, Joshi R, Arber D
Appl Immunohistochem Mol Morphol
. 2018 Apr;
27(6):416-422.
PMID: 29629950
Here, we utilize a high throughput sequencing panel that covers several genes known to be recurrently mutated in certain T-cell lymphoma subtypes as well as genes frequently mutated in other...
8.
Joshi R, Gomez C, Steiner D, Aziz N, Pinsky B
J Clin Microbiol
. 2017 Nov;
55(12):3566-3567.
PMID: 29180505
No abstract available.
9.
Joshi R, Gomez C, Steiner D, Aziz N, Pinsky B
J Clin Microbiol
. 2017 Nov;
55(12):3316-3320.
PMID: 29180504
No abstract available.
10.
Shaffer S, Joshi R, Chambers B, Sterken D, Biaesch A, Gabrieli D, et al.
Lab Chip
. 2015 Jun;
15(15):3170-82.
PMID: 26113495
Viral infections are a major cause of human disease, but many require molecular assays for conclusive diagnosis. Current assays typically rely on RT-PCR or ELISA; however, these tests often have...